Bone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Completed · Phase 2
Conditions studied: Secondary Hyperparathyroidism
In brief
The purpose of this study is to evaluate the effects of cinacalcet on markers of bone turnover in patients with kidney disease who are receiving dialysis.
Key facts
- Study ID
- NCT00261950
- Run by
- Amgen
- People needed
- 110
- Starts
- 2006-05-01
- Expected to finish
- 2011-05-01
- Last updated by the study team
- 2014-07-21
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Research Site — Los Angeles, California, United States
- Research Site — Denver, Colorado, United States
- Research Site — New Haven, Connecticut, United States
- Research Site — Fort Lauderdale, Florida, United States
- Research Site — Evanston, Illinois, United States
- Research Site — New Orleans, Louisiana, United States
- Research Site — Baltimore, Maryland, United States
- Research Site — St Louis, Missouri, United States
- Research Site — Teaneck, New Jersey, United States
- Research Site — Flushing, New York, United States
- Research Site — Great Neck, New York, United States
- Research Site — New York, New York, United States
- Research Site — The Bronx, New York, United States
- Research Site — Allentown, Pennsylvania, United States
- Research Site — Houston, Texas, United States
- Research Site — Antwerp, Belgium
- Research Site — Antwerp, Belgium
- Research Site — Brussels, Belgium
- Research Site — Leuven, Belgium
- Research Site — Liège, Belgium
- Research Site — Hradec Králové, Czechia
- Research Site — Prague, Czechia
- Research Site — Budapest, Hungary
- Research Site — Debrecen, Hungary
- Research Site — Phoenix, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.